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Sir,
Stevenson et al (2003) have analysed the level of consensus on
the priorities for cancer care among health professionals who treat
rural cancer patients in Northeast Scotland. Cancer care in this
health area centralises oncology specialists in the city of Aberdeen,
although approximately half of its 500000 population live in rural
areas. The authors found a single disagreement among the
participant health professionals: which is the best location for
chemotherapy delivery (central vs. local). In our opinion, such a
predicament should be formulated in a different way, so that one
alternative does not rule out the other. The question should
possibly be whether local treatment can be compatible with central
treatment in a public health system.
The organizational structure of the Catalan Institute of Oncology
(ICO) has addressed the issue of decentralization of cancer care
and treatment delivery, and may provide valuable experience to
help formulating a more appropriate question. The ICO is the
major cancer care provider in Catalonia, serving a population of
2.5 million in three cancer centers: Duran i Reynals (l’Hospitalet,
Barcelona), Dr Josep Trueta (Girona), and Germans Trias i Pujol
(Badalona, Barcelona). The ICO began its operations in 1995 in
l’Hospitalet, and expanded to Girona and Badalona in 2002 and
2003, respectively. A major strength of the organization has been
its ability to reach agreements between each of the three centres
and the community hospitals in their respective regions. The
agreements are flexible, and allow for oncology specialists
consultation only and for full chemotherapy prescription and
administration. The health network established by ICO allows
for the planning of chemotherapy delivery according to
community hospital needs and also by cancer type, the
chemotherapy regimen, and the complexity of treatment. For
example, some community hospitals deliver most types of
chemotherapy to the majority of cancer patients, while others
deliver only adjuvant chemotherapy in breast or colon cancer
patients. Patients included in clinical trials are usually treated
centrally during the study protocol. The agreements are signed
annually and can be modified.
Our cancer care experience strongly points out that the future of
cancer treatment delivery in rural areas must not be either local or
central, but rather a judicious combination of the two.
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